Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beate Sander

Showing results (51-60 of 205) with videos related to

Pageof 21
Sort By:
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 6, 2005
Influenza treatment with neuraminidase inhibitors: cost-effectiveness and cost-utility in healthy adults in the United KingdomBeate Sander, Marlene Gyldmark, Frederick G Hayden, et al.
BMC Health Services Research|December 30, 2022
Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: a systematic reviewGirma Tekle Gebremariam, Atalay Mulu Fentie, Kebede Beyene, et al.
Pediatrics|May 2, 2019
Cost-effectiveness of Palivizumab for Respiratory Syncytial Virus: A Systematic ReviewStephen Mac, Amanda Sumner, Samuel Duchesne-Belanger, et al.
BMC Research Notes|December 15, 2011
Variability in transmissibility of the 2009 H1N1 pandemic in Canadian communitiesLuiz C Mostaço-Guidolin, Amy Greer, Beate Sander, et al.
Journal of Medical Economics|February 9, 2023
The epidemiology and healthcare costs of community-acquired pneumonia in Ontario, Canada: a population-based cohort studyRyan O'Reilly, Hong Lu, Jeffrey C Kwong, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 23, 2021
National consensus quality indicators to assess quality of care for active surveillance in low-risk prostate cancer: An evidence-informed, modified Delphi survey of Canadian urologists/radiation oncologistsNarhari Timilshina, Antonio Finelli, George Tomlinson, et al.
Expert Review of Vaccines|April 3, 2025
Economic analysis of 15-valent and 20-valent pneumococcal conjugate vaccines among older adults in Ontario, CanadaGebremedhin B Gebretekle, Ryan O'Reilly, Stephen Mac, et al.
American Journal of Clinical Oncology|May 5, 2018
Nivolumab in the Treatment of Metastatic Renal Cell Carcinoma: A Cost-Utility AnalysisJacques Raphael, Zhuolu Sun, Georg A Bjarnason, et al.
BMJ Global Health|February 27, 2024
The economic impact of international travel measures used during the COVID-19 pandemic: a scoping reviewYing Liu Bazak, Beate Sander, Eric Werker, et al.
Health and Quality of Life Outcomes|March 18, 2020
Health-related quality of life and associated factors among cervical cancer patients at Tikur Anbessa specialized hospital, Addis Ababa, EthiopiaLiya Teklu Araya, Teferi Gedif Fenta, Beate Sander, et al.
Pageof 21

Showing results (51-60 of 205) with videos related to

Sort By:
Pageof 21
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 6, 2005
Influenza treatment with neuraminidase inhibitors: cost-effectiveness and cost-utility in healthy adults in the United KingdomBeate Sander, Marlene Gyldmark, Frederick G Hayden, et al.
BMC Health Services Research|December 30, 2022
Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: a systematic reviewGirma Tekle Gebremariam, Atalay Mulu Fentie, Kebede Beyene, et al.
Pediatrics|May 2, 2019
Cost-effectiveness of Palivizumab for Respiratory Syncytial Virus: A Systematic ReviewStephen Mac, Amanda Sumner, Samuel Duchesne-Belanger, et al.
BMC Research Notes|December 15, 2011
Variability in transmissibility of the 2009 H1N1 pandemic in Canadian communitiesLuiz C Mostaço-Guidolin, Amy Greer, Beate Sander, et al.
Journal of Medical Economics|February 9, 2023
The epidemiology and healthcare costs of community-acquired pneumonia in Ontario, Canada: a population-based cohort studyRyan O'Reilly, Hong Lu, Jeffrey C Kwong, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 23, 2021
National consensus quality indicators to assess quality of care for active surveillance in low-risk prostate cancer: An evidence-informed, modified Delphi survey of Canadian urologists/radiation oncologistsNarhari Timilshina, Antonio Finelli, George Tomlinson, et al.
Expert Review of Vaccines|April 3, 2025
Economic analysis of 15-valent and 20-valent pneumococcal conjugate vaccines among older adults in Ontario, CanadaGebremedhin B Gebretekle, Ryan O'Reilly, Stephen Mac, et al.
American Journal of Clinical Oncology|May 5, 2018
Nivolumab in the Treatment of Metastatic Renal Cell Carcinoma: A Cost-Utility AnalysisJacques Raphael, Zhuolu Sun, Georg A Bjarnason, et al.
BMJ Global Health|February 27, 2024
The economic impact of international travel measures used during the COVID-19 pandemic: a scoping reviewYing Liu Bazak, Beate Sander, Eric Werker, et al.
Health and Quality of Life Outcomes|March 18, 2020
Health-related quality of life and associated factors among cervical cancer patients at Tikur Anbessa specialized hospital, Addis Ababa, EthiopiaLiya Teklu Araya, Teferi Gedif Fenta, Beate Sander, et al.
Pageof 21